Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
BCRF’s first venture funding is going to Clairity Inc., which uses AI to analyze routine mammograms and predict a woman’s five-year risk of developing cancer.
New research could provide useful information for cancer registries and potentially help policymakers better evaluate screening outcomes to develop more effective guidelines.
“Optimizing BCS within the LCS population may have the potential to reduce screening disparities and increase early breast cancer detection," researchers write in JACR.
ABUS represents a viable imaging alternative that could compensate for many of the known issues with handheld ultrasound scanners, researchers suggest.
Experts from MIT, where the technology was developed, are optimistic their system can be used by almost anyone, including individuals with no ultrasound experience.
Researchers believe the technique also could have utility for brain, head and neck MRI applications and could eventually be adapted to other imaging modalities as well.
Breast cancer risk scores change over time, with those who go on to develop cancer showing unique patterns that could provide valuable guidance into their diagnostic needs.
The manufacturer issued an alert in January, indicating its Brevera Breast Biopsy System Disposable 9 Gauge Needles were being recalled amid risk they might leave metallic particles in tissue.